These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17696971)

  • 1. Lack of systemic absorption of lidocaine from 5% patches placed on horses.
    Bidwell LA; Wilson DV; Caron JP
    Vet Anaesth Analg; 2007 Nov; 34(6):443-6. PubMed ID: 17696971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of lidocaine in dogs following lidocaine patch application.
    Ko J; Weil A; Maxwell L; Kitao T; Haydon T
    J Am Anim Hosp Assoc; 2007; 43(5):280-3. PubMed ID: 17823477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of lidocaine following the application of 5% lidocaine patches to cats.
    Ko JC; Maxwell LK; Abbo LA; Weil AB
    J Vet Pharmacol Ther; 2008 Aug; 31(4):359-67. PubMed ID: 18638297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of continuously applied lidocaine patches 5%.
    Gammaitoni AR; Alvarez NA; Galer BS
    Am J Health Syst Pharm; 2002 Nov; 59(22):2215-20. PubMed ID: 12455305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of application durations and heat on the pharmacokinetic properties of drug delivered by a lidocaine/tetracaine patch: a randomized, open-label, controlled study in healthy volunteers.
    Marriott TB; Charney MR; Stanworth S
    Clin Ther; 2012 Oct; 34(10):2174-83. PubMed ID: 22943969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
    Gammaitoni AR; Davis MW
    Ann Pharmacother; 2002 Feb; 36(2):236-40. PubMed ID: 11847940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a lidocaine patch 5% in dogs.
    Weiland L; Croubels S; Baert K; Polis I; De Backer P; Gasthuys F
    J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):34-9. PubMed ID: 16411907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disposition of lidocaine during a 12-hour intravenous infusion to postoperative horses.
    Milligan M; Kukanich B; Beard W; Waxman S
    J Vet Pharmacol Ther; 2006 Dec; 29(6):495-9. PubMed ID: 17083453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of gastrointestinal tract disease on pharmacokinetics of lidocaine after intravenous infusion in anesthetized horses.
    Feary DJ; Mama KR; Thomasy SM; Wagner AE; Enns RM
    Am J Vet Res; 2006 Feb; 67(2):317-22. PubMed ID: 16454639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can fractional lasers enhance transdermal absorption of topical lidocaine in an in vivo animal model?
    Oni G; Brown SA; Kenkel JM
    Lasers Surg Med; 2012 Feb; 44(2):168-74. PubMed ID: 22302761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of lidocaine in dogs following lidocaine patch application over an incision compared to intact skin.
    Joudrey SD; Robinson DA; Kearney MT; Papich MG; da Cunha AF
    J Vet Pharmacol Ther; 2015 Dec; 38(6):575-80. PubMed ID: 25846945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of lignocaine in Icelandic horses after infiltration anaesthesia.
    Kristinsson J; Thordarson TH; Johannesson T
    Vet Rec; 1996 Feb; 138(5):111-2. PubMed ID: 8650905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lidocaine patch 5%.
    Comer AM; Lamb HM
    Drugs; 2000 Feb; 59(2):245-9; discussion 250-1. PubMed ID: 10730547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster.
    Campbell BJ; Rowbotham M; Davies PS; Jacob P; Benowitz NL
    J Pharm Sci; 2002 May; 91(5):1343-50. PubMed ID: 11977110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of lidocaine patches.
    Weil AB; Ko J; Inoue T
    Compend Contin Educ Vet; 2007 Apr; 29(4):208-10, 212, 214-6. PubMed ID: 17726850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic exposure to lidocaine and tetracaine is low after an application of a lidocaine 7%-tetracaine 7% peel in adults.
    Ogden L; Love G; Basta S
    Int J Dermatol; 2008 Jan; 47(1):87-90. PubMed ID: 18173612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine in the horse: its pharmacological effects and their relationship to analytical findings.
    Harkins JD; Mundy GD; Woods WE; Lehner A; Karpiesiuk W; Rees WA; Dirikolu L; Bass S; Carter WG; Boyles J; Tobin T
    J Vet Pharmacol Ther; 1998 Dec; 21(6):462-76. PubMed ID: 9885969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of anorectal nifedipine and lidocaine (lignocaine) ointment following haemorrhoidectomy: an open-label, single-dose, phase IV clinical study.
    Perrotti P; Dominici P; Grossi E; Antropoli C; Giannotti G; Cusato M; Regazzi M; Cerutti R
    Clin Drug Investig; 2009; 29(4):243-56. PubMed ID: 19301938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated lidocaine serum levels following the use of a needle free device in healthy adult volunteers.
    Gulur P; El Saleeby C; Watt LD; Koury KM; Cohen AR
    Pediatr Emerg Care; 2014 May; 30(5):335-9. PubMed ID: 24786988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro transdermal permeation of lidocaine-dodecanol binary eutectic system].
    Ke GM; Wang L; Wang P; Lu WL; Wang SM; Zhang Q; Guo HY
    Yao Xue Xue Bao; 2005 Aug; 40(8):764-8. PubMed ID: 16268515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.